Physician profile
Shaoxu Bing
NPI 1497287502
$8,295.43
in general payments reported to CMS, 2019-2025
13 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,443 · 2023: $4,689 · 2024: $1,873 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,000 · Food and Beverage: $1,401 · Travel and Lodging: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,000.00 |
| Food and Beverage | $1,401.14 |
| Travel and Lodging | $451.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,374.35 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $273.85 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Cook Medical LLC | $133.18 | 2022 | |
| Davol INC. | $107.21 | 2024-2025 | Phasix Mesh |
| Atricure, INC. | $100.68 | 2022 | |
| Medtronic, INC. | $66.66 | 2025 | Progrip |
| Procept Biorobotics Corporation | $58.20 | 2024 | Aquabeam System |
| Conmed Corporation | $50.09 | 2024 | Airseal |
| Ethicon US, LLC | $43.16 | 2023 | Echelon Flex |
| Becton, Dickinson and Company | $36.79 | 2023 | Phasix Mesh |
| Integra Lifesciences Corporation | $22.10 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $14.59 | 2023 | |
| Abbvie INC. | $14.57 | 2023 | Dalvance, Teflaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaoxu Bing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.